Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
NIH updates its strategic plan for hepatitis B research

NIH updates its strategic plan for hepatitis B research

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

Transplant remains the standard of care for liver cancer patients, regardless of age

Transplant remains the standard of care for liver cancer patients, regardless of age

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

Alcohol consumption does not provide any health benefits, presents many risks for young people

Alcohol consumption does not provide any health benefits, presents many risks for young people

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

New liquid biopsy test found to be highly accurate, sensitive for both NASH and liver fibrosis

New liquid biopsy test found to be highly accurate, sensitive for both NASH and liver fibrosis

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

Studies discover multiple gene variants that contribute to the risk  and severity of NAFLD in children

Studies discover multiple gene variants that contribute to the risk and severity of NAFLD in children

Inhibiting pore formation in cells may facilitate prevention, treatment of NASH-associated liver cancer

Inhibiting pore formation in cells may facilitate prevention, treatment of NASH-associated liver cancer

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

Simple blood test can predict liver cancer risk in NAFLD patients

Simple blood test can predict liver cancer risk in NAFLD patients

Conceptual framework to examine the patterns of copy number alterations in human cancer

Conceptual framework to examine the patterns of copy number alterations in human cancer

Targeting macropinocytosis may be an effective therapeutic approach for hepatocellular carcinoma

Targeting macropinocytosis may be an effective therapeutic approach for hepatocellular carcinoma

New machine learning algorithm finds a gene signature characteristic of tumors

New machine learning algorithm finds a gene signature characteristic of tumors

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Interactive web portal details the extent of splicing events in noncoding sequences

Interactive web portal details the extent of splicing events in noncoding sequences